US 11,945,779 B2
Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cells
Byoung-Mog Kwon, Daejeon (KR); Dong Cho Han, Daejeon (KR); Yae Jin Yoon, Daejeon (KR); Yu Jin Lee, Daejeon (KR); Jiyoun Choi, Daejeon (KR); and Sangku Lee, Daejeon (KR)
Assigned to VSPHARMTECH, Daegu (KR)
Appl. No. 17/052,865
Filed by VSpharmtech, Daegu (KR)
PCT Filed May 2, 2019, PCT No. PCT/KR2019/005277
§ 371(c)(1), (2) Date Nov. 4, 2020,
PCT Pub. No. WO2019/212261, PCT Pub. Date Nov. 7, 2019.
Claims priority of application No. 10-2018-0051936 (KR), filed on May 4, 2018.
Prior Publication US 2021/0246105 A1, Aug. 12, 2021
Int. Cl. A61K 31/445 (2006.01); A23L 33/10 (2016.01); A61K 45/06 (2006.01); C07D 211/14 (2006.01)
CPC C07D 211/14 (2013.01) [A23L 33/10 (2016.08); A61K 45/06 (2013.01)] 8 Claims
 
1. A compound having a structure of the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof, as a benproperine derivative compound:

OG Complex Work Unit Chemistry